$MRK

Robert M. Davis

Merck

Chairman & CEO • Since 2021 • Health Care

Also profiled in: Dow Jones

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

32/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $18.1B → $12.4B (−31.7% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $17.1B → $18.3B (+6.6% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Robert M. Davis is the chairman & ceo of Merck since 2021. Merck is a Health Care company headquartered in Kenilworth, New Jersey, founded in 1891, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Robert holds the chief executive role at Merck with the title Chairman & CEO — in post since 2021. This page is the concise leadership record for Merck in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $MRK
Headquarters: Kenilworth, New Jersey
Founded: 1891
CEO since: 2021
Index: S&P 500 (#306 of 500)